scientifyRESEARCH
research funding database

RESEARCH FUNDING

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) (worldwide)

Share this post

Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange plus symbol appears between the two logos.
Free trial

The Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) funding from the National Institutes of Health (NIH) supports translational and clinical research to

  1. advance precision medicine in pregnant persons, lactating persons, and children through the development of novel tools, models, and other technologies that could have a direct clinical or health impact;
  2. enhance the understanding of the underlying mechanisms of drug action, including the role of pediatric ontogeny and the dynamic physiological changes that occur during pregnancy and lactation; and
  3. discover and develop novel therapeutics or enhance the usage of existing drugs or drug repurposing for safer and more effective medications in pregnant and lactating persons, neonates, and children.

The overall goal is to improve safe and effective precision therapeutics for pregnant and lactating persons, fetuses, neonates, and children, including those with disabilities. An R21 grant application need not have extensive background material or preliminary information. Applications are open to researchers in the USA and worldwide. Applicants may apply for up to 275,000 USD in direct costs for up to 2 years.

Opportunity number: PAR-23-131

Letters of intent are due: May 16, 2024.

Applications are due: June 16, 2024.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for our monthly
research funding newsletter

you can unsubscribe at any time

Be the first to know

Sign-up for Personalized Grant Alerts

Logo3